The Concentration of Memantine in the Cerebrospinal Fluid of Alzheimer’s Disease Patients and Its Consequence to Oxidative Stress Biomarkers

Memantine is a noncompetitive N-methyl-d-aspartate (NMDA) receptor antagonist utilized as a palliative cure for Alzheimer’s disease. This is the second study examining the memantine concentrations in cerebrospinal fluid. The previously published study enrolled six patients, and three of them were th...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Pharmacol
Päätekijät: Valis, Martin, Herman, David, Vanova, Nela, Masopust, Jiri, Vysata, Oldrich, Hort, Jakub, Pavelek, Zbysek, Klimova, Blanka, Kuca, Kamil, Misik, Jan, Zdarova Karasova, Jana
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2019
Aiheet:
Pharmacology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6722429/
https://ncbi.nlm.nih.gov/pubmed/31555132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00943
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia